Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2022-06-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
111年5月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanations for the changes. It is a brief financial data summary without detailed financial statements or comprehensive analysis. The document length is short (803 characters), and it does not contain full financial reports or management discussion. It fits the description of a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2022-06-09 Chinese
公告本公司第四屆薪資報酬委員會委員任期屆滿
Remuneration Information Classification · 95% confidence The document is a short announcement (804 characters) about the expiration of the term of members of the company's Remuneration Committee and the pending reappointment by the board. It includes names, roles, and dates related to committee membership changes. There is no financial data, no detailed report, no financial results, and no mention of a report being attached or published. The content relates to changes in a board committee, specifically the Remuneration Committee, which falls under Remuneration Information filings. Therefore, the document is best classified as Remuneration Information (DEF 14A).
2022-06-08 Chinese
公告本公司審計委員會委員任期屆滿異動
Board/Management Information Classification · 95% confidence The document is a short announcement (861 characters) about changes in the Audit Committee members' term expiration and reappointment. It details the names of outgoing and incoming members, their roles, and the effective dates. There is no financial data, no report attached or referenced as being published, and no mention of financial results or other report types. This fits the category of Board/Management Information (MANG), as it concerns changes in a company's board-level committee members. The document is not a full report but an announcement of management/board changes.
2022-06-08 Chinese
公告本公司董事會推選張立秋先生續任董事長
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the reappointment of a company's chairman following a board resolution. It includes details such as the date of the board decision, the name and position of the individual, and the reason for the change (term expiration and shareholder meeting re-election). There is no financial data, no mention of financial results, reports, or regulatory filings beyond the board/management change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-06-08 Chinese
公告本公司股東常會通過解除新任董事及其代表人競業禁止之限制
Board/Management Information Classification · 95% confidence The document is a regulatory announcement from a listed company (1760 寶齡富錦) regarding a shareholder meeting resolution to lift restrictions on new directors and their representatives engaging in competitive activities. It includes details about the meeting date, names and titles of directors involved, the scope and period of permitted competitive activities, and voting results. The content is focused on board/management decisions and governance matters rather than financial results, audit, or other report types. It is not a full report but an announcement of a board/management related decision. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and specific to management decisions, not a report or announcement of a report publication.
2022-06-08 Chinese
公告本公司111年股東常會改選董事
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the election and changes in the company's board of directors following the Annual General Meeting (AGM). It details the names, titles, and shareholdings of outgoing and newly appointed directors, the effective date of the changes, and the reason for the changes (board term expiration and full re-election). The document is short (1840 characters) and focuses solely on board member changes without financial data or broader report content. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-06-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.